Search Ontology:
ChEBI
(3R,10S,13S,16S,19S)-16-[(2R)-butan-2-yl]-3-(3-chloro-2-hydroxypropyl)-10,11,14-trimethyl-13-propan-2-yl-4-oxa-1,8,11,14,17-pentazabicyclo[17.3.0]docosane-2,5,9,12,15,18-hexone
- Term ID
- CHEBI:182855
- Synonyms
-
- (3R,10S,13S,16S,19S)-16-[(2R)-butan-2-yl]-3-(3-chloro-2-hydroxypropyl)-10,11,14-trimethyl-13-propan-2-yl-4-oxa-1,8,11,14,17-pentazabicyclo[17.3.0]docosane-2,5,9,12,15,18-hexone
- Definition
- References
- Ontology
- ChEBI ( EBI )
- is a type of
-
Show first 5 Terms
Phenotype
Phenotype resulting from (3R,10S,13S,16S,19S)-16-[(2R)-butan-2-yl]-3-(3-chloro-2-hydroxypropyl)-10,11,14-trimethyl-13-propan-2-yl-4-oxa-1,8,11,14,17-pentazabicyclo[17.3.0]docosane-2,5,9,12,15,18-hexone
Phenotype where environments contain (3R,10S,13S,16S,19S)-16-[(2R)-butan-2-yl]-3-(3-chloro-2-hydroxypropyl)-10,11,14-trimethyl-13-propan-2-yl-4-oxa-1,8,11,14,17-pentazabicyclo[17.3.0]docosane-2,5,9,12,15,18-hexone
Phenotype modified by environments containing (3R,10S,13S,16S,19S)-16-[(2R)-butan-2-yl]-3-(3-chloro-2-hydroxypropyl)-10,11,14-trimethyl-13-propan-2-yl-4-oxa-1,8,11,14,17-pentazabicyclo[17.3.0]docosane-2,5,9,12,15,18-hexone
Human Disease Model